Anti-inflammatory mode of isoflavone glycoside sophoricoside by inhibition of interleukin-6 and cyclooxygenase-2 in inflammatory response

Arch Pharm Res. 2003 Apr;26(4):306-11. doi: 10.1007/BF02976960.

Abstract

Soy, high dietary intake for the oriental population, is a main source of isoflavonoids. Sophoricoside (SOP) an isoflavone glycoside was isolated from immature fruits of Sophora japonica (Leguminosae family) and its inhibitory effect on chemical mediators involved in inflammatory response was investigated in this study. SOP inhibited the interleukin (IL)-6 bioactivity with an IC50 value of 6.1 microM whereas it had no effects on IL-1beta and TNF-alpha bioactivities. SOP was identified as a selective inhibitor of cyclooxygenase (COX)-2 activity with an IC50 value of 4.4 microM, but did not show inhibitory effect on the synthesis of COX-2. However, SOP had no effect on the production of reactive oxygen species including superoxide anions and nitric oxide. These results revealed that in vitro anti-inflammatory action of SOP is significantly different from that of genistein known as a phytoestrogen of soy products. This experimental study has documented an importance of dietary soy isoflavonoids as multifunctional agents beneficial to human health, and will help to clarify protective mechanisms of SOP against inflammatory conditions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology*
  • Benzopyrans / pharmacology*
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Humans
  • In Vitro Techniques
  • Inflammation / chemically induced
  • Inflammation / drug therapy*
  • Inflammation / prevention & control*
  • Interleukin-1 / metabolism
  • Interleukin-6 / antagonists & inhibitors*
  • Isoenzymes / adverse effects
  • Isoenzymes / antagonists & inhibitors*
  • Korea
  • Membrane Proteins
  • Mice
  • Nitric Oxide / antagonists & inhibitors*
  • Nitric Oxide / metabolism
  • Plant Structures / chemistry
  • Prostaglandin-Endoperoxide Synthases / adverse effects
  • Reactive Oxygen Species / antagonists & inhibitors*
  • Reactive Oxygen Species / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anti-Inflammatory Agents
  • Benzopyrans
  • Interleukin-1
  • Interleukin-6
  • Isoenzymes
  • Membrane Proteins
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • sophoricoside
  • Nitric Oxide
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • PTGS1 protein, human
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases
  • Ptgs1 protein, mouse